Kite Pharma
Los Angeles · Founded 2009
About Kite Pharma
Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.
Company Facts
- Founded: 2009
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $335.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Dec 2015)
- Ticker: nasdaq:KITE
- Website: kitepharma.com
- Phone: (310) 824-9999
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kite-pharma-211322 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.